Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
120 mg sildenafil citrate by mouth
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
25% sildenafil cream
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 50 💬
3Access program - sildenafil citrate, Viagra, Revatio
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
4Bosentan and Sildenafil
(D08514)		2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil (D08514) 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
5Duo-Therapy with Sildenafil + Bosentan
(D08514)		2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil (D08514) 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
6ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)
(D08514)		4件: Bosentan,
Macitentan,
Sildenafil,
Tadalafil		5件: Bosentan ,
Tadalafil ,
Bosentan ,
Sildenafil (D08514),
Macitentan 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7G04BE03- Sildenafil - sildenafil (citrato)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
8Mono-Therapy with Sildenafil
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
9Oral sildenafil
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
10Sildenafil
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
11Sildenafil (50 mg)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 85 💬
12Sildenafil (Acute-1 hour)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
13Sildenafil (as citrate)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
14Sildenafil (REVATIO)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
15Sildenafil (Revatio) 20 mg TID
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
16Sildenafil (Subchronic-4 weeks)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
17Sildenafil 20 mg tablets
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 278 💬
18Sildenafil 20mg
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
19Sildenafil 20mg and Bosentan 62.5mg
(D08514)		2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil (D08514) 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
20Sildenafil 40mg oral capsule
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 299 💬
21Sildenafil and Losartan
(D08514)		2件: Losartan,
Sildenafil		2件: Losartan ,
Sildenafil (D08514) 💬		2件: AGTR1,
PDE5A 💬		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 85 💬
22Sildenafil by injection
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 210 💬
23SILDENAFIL CITRATE
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬4件: 51, 85, 86, 225 💬
24Sildenafil citrate (UK-92,480)
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
25Sildenafil Filmtabletten
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
26Sildenafil Oral Suspension
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294 💬
27Sildenafil singly or in association with Bosentan
(D08514)		2件: Bosentan,
Sildenafil		3件: Bosentan ,
Bosentan ,
Sildenafil (D08514) 💬		3件: EDNRA,
EDNRB,
PDE5A 💬		11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
28Sildenafil therapy
(D08514)		1件: Sildenafil1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 51 💬
29Sitaxsentan and Sildenafil
(D08514)		2件: Sildenafil,
Sitaxentan		2件: Sitaxentan ,
Sildenafil (D08514) 💬		2件: EDNRA,
PDE5A 💬		9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
30Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth
(D08514)		2件: Dextrose, unspecified form,
Sildenafil		1件: Sildenafil (D08514) 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86 💬
31Tadalafil and Sildenafil
(D08514)		2件: Sildenafil,
Tadalafil		2件: Tadalafil ,
Sildenafil (D08514) 💬		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 113 💬